Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2003
05/08/2003US20030088199 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
05/08/2003US20030088176 Non-invasive methods for surgery in the vasculature
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030087985 Gels for encapsulation of biological materials
05/08/2003US20030087967 Translucent nanoemulsion, production method, and uses thereof in the cosmetic, dermatological and/or opthalmological fields
05/08/2003US20030087954 Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
05/08/2003US20030087953 Method for treating colorectal carcinoma using a taxane/tocopherol formulation
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087893 Compositions containing alpha-2-adrenergic agonist components
05/08/2003US20030087885 Treating sexual disorders
05/08/2003US20030087877 Biologically active conjugate of a biopolymer and a therapeutic agent joined by a disulfide bond
05/08/2003US20030087844 Ribavirin syrup formulations
05/08/2003US20030087837 Compositions and methods for delivery of poorly water soluble drugs and methods of treatment
05/08/2003US20030087826 Conjugates comprising two active agents
05/08/2003US20030087808 Antidiabetic agents
05/08/2003US20030087806 Freeze dried complex; therapy for amyotrophic lateral sclerosis, antidiabetic agents
05/08/2003US20030087789 Emulsion containing a plant extract, method for producing said emulsion and for obtaining a plant extract
05/08/2003US20030087785 Reduced immunology response; antiallergens; genetic engineering
05/08/2003US20030087436 Process for the production of biologically active polymeric nanoparticle-nucleic acid conjugates
05/08/2003US20030087434 Process for selective expression of nucleic acid products
05/08/2003US20030087338 Adhesive DOPA-containing polymers and related methods of use
05/08/2003US20030087323 Specific monoclonal antibody against terbinafine
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003US20030086982 Additional substance is added to the spray-drying process in a dry form during spray-drying to prepare dry extract from liquid extract
05/08/2003US20030086977 Forming a free- standing powder comprising at least one antimicrobial metal with atomic disorder; and injecting the free-standing powder in therapeutically effective amounts to the tissue which is to be treated
05/08/2003US20030086976 Pharmaceutical compositions for poorly soluble drugs
05/08/2003US20030086973 Systems, methods and apparatuses for manufacturing dosage forms
05/08/2003US20030086972 Time-release agents; drug delivery; therapy
05/08/2003US20030086971 For therapy of allergic and/or inflammatory conditions of the skin and airway passages
05/08/2003US20030086966 Antihistamine formulations for soft gelatin dosage forms
05/08/2003US20030086964 Methods and compositions for polyene antibiotics with reduced toxicity
05/08/2003US20030086961 Composition and method
05/08/2003US20030086956 Nontoxic pesticide, and method of using the same
05/08/2003US20030086948 For decreasing the effect of intestinal metabolism on a drug
05/08/2003US20030086939 Methods to improve immunogenicity of antigens and specificity of antibodies
05/08/2003US20030086933 Therapeutic systems
05/08/2003US20030086924 Treatment with anti-ErbB2 antibodies
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003US20030086895 For sustained release of the encapsulated therapeutic agent after administration
05/08/2003US20030086883 Including in cosmetic a heteropolymer comprising a polymer skeleton which comprises at least one hydrocarbon-based repeating unit comprising at least one hetero atom in an amount effective to disperse at least one coloring agent
05/08/2003US20030086881 Antiinfective combinations and their use for the topical treatment of fungal infections of the toenails and fingernails
05/08/2003US20030086880 Antimicrobial artificial nail composition and methods for preparing and using same
05/08/2003US20030086876 Pharmaceutical formulation of fluticasone propionate
05/08/2003US20030086867 Blood clot-targeted nanoparticles
05/08/2003US20030085480 Preparation of powder agglomerates
05/08/2003DE20219829U1 Vaccine formulation against bacterial, viral, mycotic, prion or parasitic infections, includes a combination of at least two paraben esters and 2-phenoxyethanol as preservative
05/08/2003CA2789114A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2466148A1 Medical compositions for intravesical treatment of bladder cancer
05/08/2003CA2466032A1 Methods and dosage forms for improving the bioavailability of therapeutic agents
05/08/2003CA2465874A1 Thymosin alpha 1 (ta1) peptides conjugates to polyethylene glycol (peg) polymers
05/08/2003CA2465369A1 Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
05/08/2003CA2464889A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464475A1 Parenteral chlorambucil for treatment of malignant and autoimmune disease and methods of use
05/08/2003CA2464346A1 Water-soluble polymer conjugates of retinoic acid
05/08/2003CA2463977A1 Method of treatment of vulval vestibulitis
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2463158A1 Depot formulations of iloperidone and a star polymer
05/08/2003CA2458850A1 Fibrin nanoparticles and uses thereof
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/07/2003EP1308500A1 Ophthalmic composition
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1308179A1 Improved endoprosthetic device
05/07/2003EP1308171A1 Pharmaceutical compositions containing dds compounds
05/07/2003EP1308170A2 Dried blood factor composition comprising trehalose
05/07/2003EP1308169A1 Reservoir composition for the topical application of sparingly soluble drugs, their production and use
05/07/2003EP1308163A1 Endoparasiticidal gel composition
05/07/2003EP1308160A1 Highly absorbable solid preparation
05/07/2003EP1308159A1 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation
05/07/2003EP1308156A1 Drug-containing solid dispersion having improved solubility
05/07/2003EP1308155A2 Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate
05/07/2003EP1307263A2 New use of lipase inhibitors
05/07/2003EP1307243A2 A medicinal aerosol formulation
05/07/2003EP1307240A2 Radiolabelled metal transport protein as imaging agent
05/07/2003EP1307233A2 Therapeutic polyanhydride compounds for drug delivery
05/07/2003EP1307232A1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
05/07/2003EP1307231A2 Transdermal drug delivery system
05/07/2003EP1307230A2 Enhancement of development of oviparous species by in ovo feeding
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307194A1 Fentanyl composition for nasal administration
05/07/2003EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/07/2003EP1307187A2 Use of 13-cis retinoic acid for the treatment of emphysema
05/07/2003EP1307182A2 Pharmaceutical composition for transdermal delivery of befloxatone
05/07/2003EP1307181A1 Novel compositions of minoxidil
05/07/2003EP1307180A1 A method of preparing a pharmaceutical composition
05/07/2003EP1307097A2 Improved solid pharmaceutical dosage formulation of hydrophobic drugs
05/07/2003EP1232165B1 Phosphorus-containing dendrimers as transfection agents
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1210138A4 Controlled delivery of bisphosphonates
05/07/2003EP1124544B1 Dry powder pharmaceutical formulation
05/07/2003EP1109532A4 Oral micro-emulsion composition of silybin
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1023051B1 Oral morphine multiparticulate formulation
05/07/2003EP1019023B1 Stabilized preparations for use in nebulizers
05/07/2003EP0957943B1 Matrix-free osteogenic devices, implants and methods of use thereof
05/07/2003EP0874621B1 [3'-DESOXY-3-OXO-MeBmT]1-[Val]2-CICLOSPORIN-CONTAINING EMULSION PHARMACEUTICAL COMPOSITIONS
05/07/2003EP0808174B1 Medicament in particle form
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1712